Group A:Huoxiang Zhengqi oral liquid+Dexamethasone+5-Hydroxytryptamine Receptor 3 Antagonists
Sponsors
West China Hospital, Sichuan University
Conditions
tumor
Phase 4
A randomized, double-blind, controlled, multicenter prospective clinical trial of Huoxiang Zhengqi Oral Liquid to prevent chemotherapy-induced nausea and vomiting following platinum-containing multi-day chemotherapy
Active, not recruitingITMCTR2000004069
Start: 2020-12-01Updated: 2023-02-20
A randomized, double-blind, controlled, multicenter prospective clinical trial of Huoxiang Zhengqi Oral Liquid to prevent chemotherapy-induced nausea and vomiting following platinum-containing multi-day chemotherapy
Active, not recruitingChiCTR2000040123
Start: 2020-12-01Updated: 2021-01-11